These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3176109)

  • 1. Comparative evaluation of microultrafiltration devices for determination of protein binding.
    Ohshima T; Johno I; Kitazawa S
    Ther Drug Monit; 1988; 10(3):310-5. PubMed ID: 3176109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microultrafiltration technique for drug-protein binding determination in plasma.
    Shah VP; Wallace SM; Riegelman S
    J Pharm Sci; 1974 Sep; 63(9):1364-7. PubMed ID: 4427256
    [No Abstract]   [Full Text] [Related]  

  • 3. Microscale ultrafiltration technique for determining free drug in 50-microL serum samples.
    Wittfoht W; Duwe K; Kuhnz W; Nau H
    Clin Chem; 1984 Jun; 30(6):878-9. PubMed ID: 6426820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrafiltration using the Amicon MPS-1 for assessing methadone plasma protein binding.
    Wilkins JN; Ashofteh A; Setoda D; Wheatley WS; Huigen H; Ling W
    Ther Drug Monit; 1997 Feb; 19(1):83-7. PubMed ID: 9029753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of parenteral nutrition fluids on the binding of therapeutic drugs to human serum in vitro.
    Bailey DN; Briggs JR
    Ther Drug Monit; 2004 Feb; 26(1):31-4. PubMed ID: 14749546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of ultrafiltration devices for assessing theophylline protein binding.
    Blanchard J; Harvey S
    Ther Drug Monit; 1990 Jul; 12(4):398-403. PubMed ID: 2396314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug protein binding in chronic renal failure: evaluation of nine drugs.
    Vanholder R; Van Landschoot N; De Smet R; Schoots A; Ringoir S
    Kidney Int; 1988 May; 33(5):996-1004. PubMed ID: 3392889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variations in protein binding of drugs in plasma and serum.
    Ohshima T; Hasegawa T; Johno I; Kitazawa S
    Clin Chem; 1989 Aug; 35(8):1722-5. PubMed ID: 2503268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrafiltration vs equilibrium dialysis for determination of free fraction.
    Bowers WF; Fulton S; Thompson J
    Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():49-60. PubMed ID: 6705427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of coadministered drugs and ethanol on the binding of therapeutic drugs to human serum in vitro.
    Bailey DN
    Ther Drug Monit; 2001 Feb; 23(1):71-4. PubMed ID: 11206047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the Amicon Centrifree micropartition system with the Sartorius SM 13249E Centrisart I device to determine protein free phenytoin concentrations.
    Zysset T; Zeugin T
    Ther Drug Monit; 1986; 8(3):346-51. PubMed ID: 3529518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of methods to determine protein-binding of drugs. Equilibrium dialysis, ultrafiltration, ultracentrifugation, gel filtration.
    Kurz H; Trunk H; Weitz B
    Arzneimittelforschung; 1977 Jul; 27(7):1373-80. PubMed ID: 578456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale for monitoring free drug levels.
    Levy RH; Moreland TA
    Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():1-9. PubMed ID: 6705421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of free valproic acid concentrations using the Amicon Micropartition MPS-1 Ultrafiltration System.
    March C; Blanke RV
    Ther Drug Monit; 1985; 7(1):115-20. PubMed ID: 3922094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of fosphenytoin, phosphate ester pro drug of phenytoin, to human serum proteins and competitive binding with carbamazepine, diazepam, phenobarbital, phenylbutazone, phenytoin, valproic acid or warfarin.
    Lai CM; Moore P; Quon CY
    Res Commun Mol Pathol Pharmacol; 1995 Apr; 88(1):51-62. PubMed ID: 7620838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein binding of five platinum compounds. Comparison of two ultrafiltration systems.
    van der Vijgh WJ; Klein I
    Cancer Chemother Pharmacol; 1986; 18(2):129-32. PubMed ID: 3791557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anaerobic serum ultrafiltration--a new method for determination of protein-binding rates of drugs under physiological conditions (author's transl)].
    Paschen K; Bautz W; Bohner J
    Arzneimittelforschung; 1976; 26(12):2137-41. PubMed ID: 1037262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Free drug monitoring.
    Chan S; Gerson B
    Clin Lab Med; 1987 Jun; 7(2):279-87. PubMed ID: 3301170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of protein binding for the interpretation of serum or plasma drug concentrations.
    Greenblatt DJ; Sellers EM; Koch-Weser J
    J Clin Pharmacol; 1982; 22(5-6):259-63. PubMed ID: 7107972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical utility of free drug monitoring.
    Dasgupta A
    Clin Chem Lab Med; 2002 Oct; 40(10):986-93. PubMed ID: 12476936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.